PolyPeptide Group AG (XSWX:PPGN) Short-Term Capital Lease Obligation : CHF4.2 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is PolyPeptide Group AG Short-Term Capital Lease Obligation?

PolyPeptide Group AG's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was CHF4.2 Mil.

PolyPeptide Group AG's quarterly Short-Term Capital Lease Obligation declined from Dec. 2022 (CHF3.5 Mil) to Jun. 2023 (CHF3.2 Mil) but then increased from Jun. 2023 (CHF3.2 Mil) to Dec. 2023 (CHF4.2 Mil).

PolyPeptide Group AG's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (CHF3.2 Mil) to Dec. 2022 (CHF3.5 Mil) and increased from Dec. 2022 (CHF3.5 Mil) to Dec. 2023 (CHF4.2 Mil).

PolyPeptide Group AG Short-Term Capital Lease Obligation Historical Data

The historical data trend for PolyPeptide Group AG's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPeptide Group AG Short-Term Capital Lease Obligation Chart

PolyPeptide Group AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

1.63

2.14

3.18

3.52

4.20

PolyPeptide Group AG Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial					3.18	3.41	3.52	3.25	4.20

PolyPeptide Group AG Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

PolyPeptide Group AG Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of PolyPeptide Group AG's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

PolyPeptide Group AG (XSWX:PPGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PolyPeptide Group AG (XSWX:PPGN) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

PPGNz:UK

Address

Neuhofstrasse 24, Baar, Zug, CHE, 6340

Website

https://www.polypeptide.com

PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives a majority of its revenue from Europe and Asia.

PolyPeptide Group AG (XSWX:PPGN) Headlines

No Headlines